“Oncogenic Shock”: Turning an Activated Kinase against the Tumor Cell

 Abstract

Accumulating evidence indicates that mutationally activated kinases are especially good targets for anti-cancer drugs. It has been suggested that this reflects a state of “oncogene addiction” of tumor cells. We recently reported experimental studies that may provide a molecular mechanism to explain such apparent dependency. We find that oncogenic kinases produce both pro-survival and pro-apoptotic signals that decay at different rates upon oncogene inactivation. Pro-survival signals are rapidly attenuated, whereas pro-apoptotic signals are relatively longer-lived. This differential signal decay creates a temporal window during which pro-apoptotic outputs from the oncogenic kinase predominate to actively promote tumor cell death upon kinase inhibition. We refer to this mechanism as “oncogenic shock”, and suggest that it has significant implications for the optimal therapeutic use of targeted kinase inhibitors.

Full Text Options
Article
Metrics
 Share
 Full Text
 Info
Pages
2878 - 2880
doi
10.4161/cc.5.24.3598
Type
Perspectives
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
“Oncogenic Shock”: Turning an Activated Kinase against the Tumor Cell